AI assistant
Sending…
Riot Platforms, Inc. — Director's Dealing 2012
May 24, 2012
30793_dirs_2012-05-24_8a6a041c-32e0-4866-b9ee-99228593490a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-05-23
Reporting Person: Hurd Donald R (SVP, Chief Commerical Officer)
More from Riot Platforms, Inc.
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 16
Board/Management Information
2026
Jan 5